SDC1 and acute coronary syndrome: While this study is not powered to assess survival outcomes, a high serum hyaluronan concentration has been associated with poor survival in patients with kidney disease [28] and syndecan-1 has been shown to be elevated in patients with acute coronary syndrome and decompensated heart failure [29].